Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.31 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.31 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.31 |
| ▸ | CSNK2A3 | Q8NEV1 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.31 |
| ▸ | GABRR1 | P24046 | 1/20 | 0.31 |
| ▸ | GABRR2 | P28476 | 1/20 | 0.31 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.31 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.31 |
| ▸ | GABRA4 | P48169 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11528858 | 0.98 | CYP1A2 (0.41) | CYP1A2LMNAPOLBCSNK2A2CSNK2B | |
| SCHEMBL873583 | 0.75 | POLB (0.50) | CYP1A2LMNAPOLBALDH1A1CYP3A4 | |
| SCHEMBL1686950 | 0.75 | CYP1A2 (0.52) | CYP1A2LMNAPOLBALDH1A1GABRA5 | |
| SCHEMBL28670137 | 0.73 | — | — | |
| SCHEMBL3302769 | 0.73 | — | — | |
| SCHEMBL12472912 | 0.72 | CYP1A2 (0.39) | CYP1A2LMNAALDH1A1TSHR | |
| SCHEMBL874320 | 0.71 | CYP1A2 (0.38) | CYP1A2LMNAPOLBALDH1A1 | |
| SCHEMBL12473222 | 0.71 | LMNA (0.41) | CYP1A2LMNAPOLB | |
| SCHEMBL878583 | 0.71 | ADORA2A (0.40) | CYP1A2LMNAPOLB | |
| SCHEMBL11603299 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114436979-A | Method for synthesizing 1,2, 4-triazole-3-methyl carboxylate | 成都化润药业有限公司 | 2022-05-06 | — | — | CN | disclosed |
| CN-111471027-B | Synthesis process of ribavirin intermediate and intermediate | 广安润康药业有限公司 | 2021-09-28 | — | — | CN | disclosed |
| CN-111471027-A | Synthesis process of ribavirin intermediate and intermediate | 广安润康药业有限公司 | 2020-07-31 | — | — | CN | disclosed |
| EP-2906640-B1 | COATING/SEALANT SYSTEMS, AQUEOUS RESINOUS DISPERSIONS, METHODS FOR MAKING AQUEOUS RESINOUS DISPERSIONS, AND METHODS OF ELECTROCOATING | PRC DESOTO INT INC (US) | 2017-11-15 | — | — | EP | disclosed |
| EP-2756043-B1 | COATING/SEALANT SYSTEMS, AQUEOUS RESINOUS DISPERSIONS, AND METHODS OF ELECTROCOATING | PRC DESOTO INT INC (US) | 2017-04-12 | — | — | EP | disclosed |
| US-9181628-B2 | Coating/sealant systems, aqueous resinous dispersions, and methods of electrocoating | PRC-DESOTO INTERNATIONAL, INC. (US) | 2015-11-10 | — | — | US | disclosed |
| EP-2906640-A1 | COATING/SEALANT SYSTEMS, AQUEOUS RESINOUS DISPERSIONS, METHODS FOR MAKING AQUEOUS RESINOUS DISPERSIONS, AND METHODS OF ELECTROCOATING | PRC-Desoto International, Inc. (US) | 2015-08-19 | — | — | EP | disclosed |
| US-9029437-B2 | Coating/sealant systems, aqueous resinous dispersions, methods for making aqueous resinous dispersions, and methods of electrocoating | PRC-DESOTO INTERNATIONAL, INC. (US) | 2015-05-12 | — | — | US | disclosed |
| EP-2756043-A2 | COATING/SEALANT SYSTEMS, AQUEOUS RESINOUS DISPERSIONS, AND METHODS OF ELECTROCOATING | PRC-Desoto International, Inc. (US) | 2014-07-23 | — | — | EP | disclosed |
| EP-1952918-B1 | METHOD FOR PRODUCING METAL PARTICLE DISPERSION, CONDUCTIVE INK USING METAL PARTICLE DISPERSION PRODUCED BY SUCH METHOD, AND CONDUCTIVE COATING FILM | TOYO INK MFG CO (JP) | 2013-05-22 | — | — | EP | disclosed |
| US-20110175040-A1 | METHOD FOR PRODUCING METAL PARTICLE DISPRESION, CONDUCTIVE INK USING METAL PARTICLE DISPERSION PRODUCED BY SUCH METHOD, AND CONDUCTIVE COATING FILM | TOYO INK MFG CO., LTD. (JP) | 2011-07-21 | — | — | US | disclosed |
| US-7981327-B2 | Method for producing metal particle dispersion, conductive ink using metal particle dispersion produced by such method, and conductive coating film | TOYO INK MFG. CO. LTD. (JP) | 2011-07-19 | — | — | US | disclosed |
| US-20090258202-A1 | Method for Producing Metal Particle Dispersion, Conductive Ink Using Metal Particle Dispersion Produced by Such Method, and Conductive Coating Film | GVP GESELLSCHAFT ZUR VERMARKTUNG DER PORENBRENNERTECHNIK MBH (DE) | 2009-10-15 | — | — | US | disclosed |
| US-20090137603-A1 | HETEROCYCLIC AMIDE COMPOUND AND USE THEREOF | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2009-05-28 | — | — | US | disclosed |
| EP-1953148-A1 | HETEROCYCLIC AMIDE COMPOUND AND USE THEREOF | Takeda Pharmaceutical Company Limited (JP) | 2008-08-06 | — | — | EP | disclosed |
| EP-1952918-A1 | METHOD FOR PRODUCING METAL PARTICLE DISPERSION, CONDUCTIVE INK USING METAL PARTICLE DISPERSION PRODUCED BY SUCH METHOD, AND CONDUCTIVE COATING FILM | Toyo Ink Mfg. Co., Ltd (JP) | 2008-08-06 | — | — | EP | disclosed |
| US-4183925-A | 7-Aminophenylacetamido-Δ3 -cephem antibacterial agents and method of use | PFIZER INC. (US) | 1980-01-15 | — | — | US | disclosed |
| US-4142046-A | BACTERICIDES, 7-AMINO-CEPHALOSPORINS | SMITHKLINE CORPORATION (US) | 1979-02-27 | — | — | US | disclosed |
| US-4060610-A | Pharmaceutical compositions comprising 7-acyl-3-(substituted triazolyl thiomethyl)-cephalosporins and methods of treating bacterial infections | SMITHKLINE CORPORATION (US) | 1977-11-29 | — | — | US | disclosed |
| US-3989694-A | ANTIBACTERIAL | SMITHKLINE CORPORATION (US) | 1976-11-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090137603-A1 | HETEROCYCLIC AMIDE COMPOUND AND USE THEREOF | MMP2, MMP9, MMP1 | CYP1A2 471/4885LMNA 3074/4885POLB 3728/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.